Editorial for “Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI‐Based Radiomics”

Journal of Magnetic Resonance ImagingEarly View Editorial Editorial for “Evaluating Upstaging in Ductal Carcinoma in Situ Using Preoperative MRI-Based Radiomics” Endre Grøvik PhD, Corresponding Author Endre Grøvik PhD [email protected] orcid.org/0000-0002-9925-1162 Department of Radiology, Division of Diagnostics, Møre and Romsdal Hospital Trust, Ålesund, Norway[email protected]Search for more papers by this authorSolveig Roth Hoff MD, PhD, Solveig Roth Hoff MD, PhD Department of Radiology, Division of Diagnostics, Møre and Romsdal Hospital Trust, Ålesund, NorwaySearch for more papers by this author Endre Grøvik PhD, Corresponding Author Endre Grøvik PhD [email protected] orcid.org/0000-0002-9925-1162 Department of Radiology, Division of Diagnostics, Møre and Romsdal Hospital Trust, Ålesund, Norway[email protected]Search for more papers by this authorSolveig Roth Hoff MD, PhD, Solveig Roth Hoff MD, PhD Department of Radiology, Division of Diagnostics, Møre and Romsdal Hospital Trust, Ålesund, NorwaySearch for more papers by this author First published: 10 January 2023 https://doi.org/10.1002/jmri.28585 Evidence Level: 5 Technical Efficacy: Stage 5 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images are more than pictures, they are data. Radiology 2016; 278: 563- 577. 2Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017; 14: 749- 762. 3Tagliafico AS, Piana M, Schenone D, Lai R, Massone AM, Houssami N. Overview of radiomics in breast cancer diagnosis and prognostication. Breast 2020; 49: 74- 80. 4Hong M, Fan S, Yu Z, et al. Evaluating upstaging in ductal carcinoma in situ using preoperative MRI-based radiomics. J Magn Reson Imaging 2022; Epub ahead of print. 5Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7- 34. 6Risom T, Glass DR, Averbukh I, et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell 2022; 185: 299- 310.e18. 7Brennan ME, Turner RM, Ciatto S, et al. Ductal carcinoma in situ at core-needle biopsy: Meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011; 260: 119- 128. 8Hou R, Grimm LJ, Mazurowski MA, et al. Prediction of upstaging in ductal carcinoma in situ based on mammographic radiomic features. Radiology 2022; 303: 54- 62. 9Harowicz MR, Saha A, Grimm LJ, et al. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer? J Magn Reson Imaging 2017; 46: 1332- 1340. 10Lee H, Park JH, Nguyen A-T, et al. Prediction of the histologic upgrade of ductal carcinoma in situ using a combined radiomics and machine learning approach based on breast dynamic contrast-enhanced magnetic resonance imaging. Front Oncol 2022; 12:1032809. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation